Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Ernexa Therapeutics Inc.

NASDAQ: ERNA · Life Sciences · 4 alerts · CIK 748592

Share price
$1.69Close, Nov 16
Market cap
$2.86M
Shares outstanding
1.69MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Ernexa Therapeutics Inc. filings on SEC EDGAR ↗

4:51 PM ET 10-Q
Financial Results

Ernexa Therapeutics Q3 2026 Results: Net Loss of $2.94M, Loss Widens

Ernexa Therapeutics reported a net loss of $12.5 million for the nine months ended September 30, 2026, which included a $2.0 million goodwill impairment charge. The company strengthened its cash position to $5.6 million through public offerings and ATM stock issuances, while research and development expenses nearly doubled compared to the prior year.

Key figure
Net loss $2.94M

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.